Market Research Logo

Global Colorectal Cancer Epidemiology and Patient Flow Analysis - 2017

Global Colorectal Cancer Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Colorectal Cancer patients study in a new report ‘Global Colorectal Cancer Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Colorectal Cancer epidemiology, Colorectal Cancer diagnosed patients, and Colorectal Cancer treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Colorectal Cancer derived from epidemiological analysis, percentage of patients diagnosed with Colorectal Cancer, and percentage of patients treated with a therapy.

The study helps executives estimate Colorectal Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Colorectal Cancer prevalence, Colorectal Cancer diagnosis rate, and Colorectal Cancer treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Colorectal Cancer Patient Flow
  • Colorectal Cancer Prevalence
  • Colorectal Cancer Diagnosed Patients
  • Colorectal Cancer Treated Patients


1. Colorectal Cancer: Disease Definition
2. Global Colorectal Cancer Patient Flow
2A. Global Colorectal Cancer Prevalence
2B. Global Colorectal Cancer Diagnosed Patients
2C. Global Colorectal Cancer Treated Patients
3. Colorectal Cancer Patient Flow in the US
3A. Colorectal Cancer Prevalence in the US
3B. Colorectal Cancer Diagnosed Patients in the US
3C. Colorectal Cancer Treated Patients in the US
4. Colorectal Cancer Patient Flow in Europe
4A. Colorectal Cancer Prevalence in Europe
4B. Colorectal Cancer Diagnosed Patients in Europe
4C. Colorectal Cancer Treated Patients in Europe
5. Colorectal Cancer Patient Flow in Germany
5A. Colorectal Cancer Prevalence in Germany
5B. Colorectal Cancer Diagnosed Patients in Germany
5C. Colorectal Cancer Treated Patients in Germany
6. Colorectal Cancer Patient Flow in France
6A. Colorectal Cancer Prevalence in France
6B. Colorectal Cancer Diagnosed Patients in France
6C. Colorectal Cancer Treated Patients in France
7. Colorectal Cancer Patient Flow in Spain
7A. Colorectal Cancer Prevalence in Spain
7B. Colorectal Cancer Diagnosed Patients in Spain
7C. Colorectal Cancer Treated Patients in Spain
8. Colorectal Cancer Patient Flow in Italy
8A. Colorectal Cancer Prevalence in Italy
8B. Colorectal Cancer Diagnosed Patients in Italy
8C. Colorectal Cancer Treated Patients in Italy
9. Colorectal Cancer Patient Flow in UK
9A. Colorectal Cancer Prevalence in UK
9B. Colorectal Cancer Diagnosed Patients in UK
9C. Colorectal Cancer Treated Patients in UK
10. Colorectal Cancer Patient Flow in Japan
10A. Colorectal Cancer Prevalence in Japan
10B. Colorectal Cancer Diagnosed Patients in Japan
10C. Colorectal Cancer Treated Patients in Japan
11. Research Methodology
List of Tables
Table 1: Global Colorectal Cancer Patient Flow, 2016
Table 2: Global Colorectal Cancer Patient Flow Forecast, 2016 - 2025
Table 3: Colorectal Cancer Patient Flow in the US, 2016
Table 4: Colorectal Cancer Patient Flow Forecast in the US, 2016 - 2025
Table 5: Colorectal Cancer Patient Flow in Europe, 2016
Table 6: Colorectal Cancer Patient Flow Forecast in Europe, 2016 - 2025
Table 7: Colorectal Cancer Patient Flow in Germany, 2016
Table 8: Colorectal Cancer Patient Flow Forecast in Germany, 2016 - 2025
Table 9: Colorectal Cancer Patient Flow in France, 2016
Table 10: Colorectal Cancer Patient Flow Forecast in France, 2016 - 2025
Table 11: Colorectal Cancer Patient Flow in Spain, 2016
Table 12: Colorectal Cancer Patient Flow Forecast in Spain, 2016 - 2025
Table 13: Colorectal Cancer Patient Flow in Italy, 2016
Table 14: Colorectal Cancer Patient Flow Forecast in Italy, 2016 - 2025
Table 15: Colorectal Cancer Patient Flow in UK, 2016
Table 16: Colorectal Cancer Patient Flow Forecast in UK, 2016 - 2025
Table 17: Colorectal Cancer Patient Flow in Japan, 2016
Table 18: Colorectal Cancer Patient Flow Forecast in Japan, 2016 - 2025
List of Figures
Figure 1: Global Colorectal Cancer Patient Flow, 2016
Figure 2: Global Colorectal Cancer Patient Flow Forecast, 2016 - 2025
Figure 3: Colorectal Cancer Patient Flow in the US, 2016
Figure 4: Colorectal Cancer Patient Flow Forecast in the US, 2016 - 2025
Figure 5: Colorectal Cancer Patient Flow in Europe, 2016
Figure 6: Colorectal Cancer Patient Flow Forecast in Europe, 2016 - 2025
Figure 7: Colorectal Cancer Patient Flow in Germany, 2016
Figure 8: Colorectal Cancer Patient Flow Forecast in Germany, 2016 - 2025
Figure 9: Colorectal Cancer Patient Flow in France, 2016
Figure 10: Colorectal Cancer Patient Flow Forecast in France, 2016 - 2025
Figure 11: Colorectal Cancer Patient Flow in Spain, 2016
Figure 12: Colorectal Cancer Patient Flow Forecast in Spain, 2016 - 2025
Figure 13: Colorectal Cancer Patient Flow in Italy, 2016
Figure 14: Colorectal Cancer Patient Flow Forecast in Italy, 2016 - 2025
Figure 15: Colorectal Cancer Patient Flow in UK, 2016
Figure 16: Colorectal Cancer Patient Flow Forecast in UK, 2016 - 2025
Figure 17: Colorectal Cancer Patient Flow in Japan, 2016
Figure 18: Colorectal Cancer Patient Flow Forecast in Japan, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report